These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 5309062)

  • 1. [Rifampicin in tuberculosis. Summary of the observations and discussion].
    Nitti V
    Arch Tisiol Mal Appar Respir; 1968 Jun; 23(6):487-96. PubMed ID: 5309062
    [No Abstract]   [Full Text] [Related]  

  • 2. [56 recent pulmonary tuberculosis cases treated with combined rifampicin-isoniazid in a controlled experiment].
    Constans P; Morin Y; Saint-Paul M; Bonnaud G; Coury C; Bariéty M
    Rev Tuberc Pneumol (Paris); 1969 Mar; 33(2):145-62. PubMed ID: 4916251
    [No Abstract]   [Full Text] [Related]  

  • 3. [Place of ethambutol associated with isoniazid or with rifampicin in the treatment of pulmonary tuberculosis].
    Lesobre R; Frey N
    Therapeutique; 1971 Apr; 47(4):387-90. PubMed ID: 5564051
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of pulmonary tuberculosis by combined rifampicin-isoniazid-streptomycin, and return to work after the 45th day].
    Kreis B; Israël L; Pretet S
    Rev Tuberc Pneumol (Paris); 1969 Dec; 33(8):1091-108. PubMed ID: 5387445
    [No Abstract]   [Full Text] [Related]  

  • 5. Trial of rifampicin in the treatment of pulmonary tuberculosis. Results at 12 months.
    Sriyabhaya N; Jarumilin A
    J Med Assoc Thai; 1972 Apr; 55(4):235-7. PubMed ID: 5022496
    [No Abstract]   [Full Text] [Related]  

  • 6. [Durable character of the sterilization of experimental tuberculosis in mice by rifampicin-isoniazid association: cortisone test].
    Grumbach F; Canetti G; Le Lirzin M
    Rev Tuberc Pneumol (Paris); 1970 Mar; 34(2):312-9. PubMed ID: 4994882
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results of initial treatment of pulmonary tuberculosis using ethambutol, isonicotinic acid hydrazide and rifampicin].
    Kesztele V; Niederkofler J
    Wien Med Wochenschr; 1970 Jun; 120(25):473-5. PubMed ID: 5518004
    [No Abstract]   [Full Text] [Related]  

  • 8. [Epidemiology of jaundice in phthisiology department: responsibility of rifampicin].
    Oury M; Tuchais E; Tuchais M
    Rev Tuberc Pneumol (Paris); 1970; 34(3):415-22. PubMed ID: 5510436
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of recent pulmonary tuberculosis with combined rifomycin-isoniazid].
    Constans P; Morin Y; Coury C; Bariety M
    Acta Tuberc Pneumol Belg; 1969; 60(3):545-53. PubMed ID: 5371679
    [No Abstract]   [Full Text] [Related]  

  • 10. [Progress in the treatment of tuberculosis. Isoniazid plus rifomycin plus myambutol equals standard therapy].
    Freerksen E
    Dtsch Med Wochenschr; 1970 Jan; 95(3):139-41. PubMed ID: 5411222
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of pulmonary tuberculosis with short course isoniazid-rifampicin regimen compared with standard regimen in ambulatory pediatric clinic.
    Trastotenojo MS; Wiroreno B; Santosa ; Soemantri AG; Hendarto T; Singgih Y
    Paediatr Indones; 1983; 23(11-12):240-9. PubMed ID: 6678404
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical results obtained by rifomycin treatment of patients with recent tuberculosis].
    Daddi G; Lucchesi M
    Acta Tuberc Pneumol Belg; 1969; 60(3):521-6. PubMed ID: 5371677
    [No Abstract]   [Full Text] [Related]  

  • 13. Lamivudine enabled isoniazid and rifampicin treatment in pulmonary tuberculosis and hepatitis B co-infection.
    Yu WC; Lai ST; Chiu MC; Chau TN; Ng TK; Tam CM
    Int J Tuberc Lung Dis; 2006 Jul; 10(7):824-5. PubMed ID: 16850548
    [No Abstract]   [Full Text] [Related]  

  • 14. [Bacteriological evolution established in 406 tuberculosis patients treated with various combinations with or without rifampicin or INH].
    Parrot R; Augier J; Auroy C; Baron A; Boscus M; Deshais B; Gillet P; Laparre C; Marchal G; Naghavi H; Plawner S; Schoepff G
    Rev Tuberc Pneumol (Paris); 1970; 34(5):709-13. PubMed ID: 5496793
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative bacteriological development in 2 groups of patients with severe pulmonary tuberculosis, 1 treated with a rifampicin-base combination, the other with an INH-base combination].
    Augier J; Parrot R; Marchal G; Gillet P
    Rev Tuberc Pneumol (Paris); 1969; 33(3):414-23. PubMed ID: 5383011
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on short-course chemotherapy of tuberculosis. II. Liver function during 6-month chemotherapy of tuberculosis with hydrazide, rifampicin and pyrazinamide].
    Nikodemowicz E; Kamińska M; Caban M; Struzik T
    Pneumonol Pol; 1984 Oct; 52(10):503-12. PubMed ID: 6533580
    [No Abstract]   [Full Text] [Related]  

  • 17. [Rifampicin in the treatment of newly detected adolescent pulmonary tuberculosis patients].
    Ganiev KG; Esanbaev DE; Kirina SB
    Probl Tuberk; 1983 May; (5):42-6. PubMed ID: 6866983
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pyridoxine metabolism in pulmonary tuberculosis patients under rifampicin therapy in combination with isoniazid].
    Baĭramaliev G; Krasheninnikova MA; Kolosovskaia VP; Chukanov VI
    Probl Tuberk; 1982 Jan; (1):58-62. PubMed ID: 7058194
    [No Abstract]   [Full Text] [Related]  

  • 19. [Severe hypoprothrombinemia in a tubercular patient treated by combined rifampicin, isoniazid, streptomycin and prothionamide].
    Hinaut G; Bosio AM; Estampes B
    Rev Tuberc Pneumol (Paris); 1970 Mar; 34(2):291-5. PubMed ID: 5510315
    [No Abstract]   [Full Text] [Related]  

  • 20. [Light and electron microscopy studies of the liver in tuberculosis patients receiving rifampin and isoniazid].
    Pilheu JA; de Salvo MC; Koch O; Barcat JA
    Medicina (B Aires); 1981; 41(4):439-45. PubMed ID: 7339434
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.